
Mayumi Nakagawa MD
Blood Banking & Transfusion Medicine, Anatomic Pathology, Clinical Pathology
Associate Professor, Pathology, University of Arkansas COM
Join to View Full Profile
4301 W Markham St"# 783"Little Rock, AR 72205
Phone+1 501-686-8000
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Mayumi Nakagawa, MD is a board certified pathologist in Little Rock, Arkansas. She is currently licensed to practice medicine in Arkansas and California. She is an Associate Professor at University of Arkansas COM.
Education & Training
- University of California (San Francisco)Residency, Pathology-Anatomic and Clinical, 1990 - 1992
- Albert Einstein College of MedicineClass of 1990
Certifications & Licensure
- AR State Medical License 2004 - 2025
- CA State Medical License 1992 - 2025
- American Board of Pathology Clinical Pathology
Publications & Presentations
PubMed
- Coinfections with additional oncoviruses in HPV+ individuals: Status, function and potential clinical implications.Lu Dai, Lillie G Wilson, Mayumi Nakagawa, Zhiqiang Qin
Journal of Medical Virology. 2024-01-01 - 1 citationsAssessing the Feasibility of an Online Module for Promoting Cancer Prevention Measures.Sumit K. Shah, Brittany E. Demmings, Milan Bimali, Kristie B. Hadden, Mayumi Nakagawa
Cancer Control. 2021-11-18 - 6 citationsExpansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion...Takeo Shibata, Sumit K. Shah, Teresa Evans, Hannah N. Coleman, Benjamin J. Lieblong
Frontiers in Immunology. 2021-09-30
Press Mentions
- UAMS Doctor Working on HPV CureMarch 23rd, 2016
- UAMS Researcher’s HPV Vaccine Holds Promise for Saving Lives, Preventing Premature BirthsMarch 9th, 2016
Grant Support
- Understanding and Enhancing T-Cell Responses to High Risk Human Papillomaviruses-RenewalUNIV OF ARKANSAS FOR MED SCIS2010–2026